These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1112694)

  • 41. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Grouping patients with kidney calculi disease].
    Larsson L; Tiselius HG
    Lakartidningen; 1978 May; 75(19):1912-3. PubMed ID: 651450
    [No Abstract]   [Full Text] [Related]  

  • 43. Metabolic studies in hypercalciuric acid hyperoxaluric children with kidney stones.
    Kepozou L; Vretos C; Lapatsanis P
    Scand J Urol Nephrol Suppl; 1980; 53():221-4. PubMed ID: 6937999
    [No Abstract]   [Full Text] [Related]  

  • 44. [pH, titrable acidity and urinary buffer power in oxalic lithiasis, gout and uric lithiasis].
    Thomas J; Thomas E; Rabussier H; Desgrez P
    J Urol Nephrol (Paris); 1968 Sep; 74(9):690-3. PubMed ID: 5718186
    [No Abstract]   [Full Text] [Related]  

  • 45. A key stone cop regulates oxalate homeostasis.
    Kleta R
    Nat Genet; 2006 Apr; 38(4):403-4. PubMed ID: 16570061
    [No Abstract]   [Full Text] [Related]  

  • 46. [Metabolic changes in the patient with recurring lithiasis. Our cases].
    Miján Ortiz JL; Muñoz Torres M; Puebla Ceverino M; García Victor F; Céspedes Mas S; Zuluaga Gómez A; Escobar Jiménez F
    Arch Esp Urol; 1991; 44(1):55-7. PubMed ID: 2064424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxalate and renal stone formation.
    Tiselius HG
    Scand J Urol Nephrol Suppl; 1980; 53():135-48. PubMed ID: 6937989
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hyperoxaluria and nephrolithiasis after ileal resection].
    Knutsen KM; Saltvedt E; Tonder M; Foss OP
    Tidsskr Nor Laegeforen; 1977 Oct; 97(29):1501-2. PubMed ID: 918920
    [No Abstract]   [Full Text] [Related]  

  • 49. [Oxalic lithiasis and disorder of uric acid metabolism].
    Mugler A
    J Urol Nephrol (Paris); 1970 Dec; 76(12):423-34. PubMed ID: 5522994
    [No Abstract]   [Full Text] [Related]  

  • 50. Dialysis in the treatment of primary hyperoxaluria.
    Zarembski PM; Rosen SM; Hodgkinson A
    Br J Urol; 1969 Oct; 41(5):530-3. PubMed ID: 5383549
    [No Abstract]   [Full Text] [Related]  

  • 51. Letter: Calcium oxalate urinary-tract stones in patients on maintenance dialysis.
    Oreopoulos DG; Silverberg S
    N Engl J Med; 1974 Jun; 290(25):1438-9. PubMed ID: 4829568
    [No Abstract]   [Full Text] [Related]  

  • 52. Oxalic acid, calcium, and phosphorus in the renal papilla of normal and stone forming rats.
    Wright RJ; Hodgkinson A
    Invest Urol; 1972 Mar; 9(5):369-75. PubMed ID: 5016022
    [No Abstract]   [Full Text] [Related]  

  • 53. [Metabolic, clinical and dietetic aspects of various types of hyperoxaluria].
    Nassi PA; Vecchi C; Acanfora D; Quarantini M
    Minerva Pediatr; 1977 May; 29(16):1087-98. PubMed ID: 875990
    [No Abstract]   [Full Text] [Related]  

  • 54. [Experimental oxalic lithiasis induced with glyoxylic acid in rats. Attempted prevention with succinimide].
    Melon JM; Thomas J; Pierre R
    Therapie; 1971; 26(5):991-8. PubMed ID: 5160351
    [No Abstract]   [Full Text] [Related]  

  • 55. Renal failure with hypercalcemia, renal stones, multiple pathologic fractures, and growth failure.
    Chesney RW; Friedman AL; Breed AL; Langer LO; Gilbert EF; Opitz JM
    Am J Med Genet; 1983 Jan; 14(1):169-79. PubMed ID: 6829606
    [No Abstract]   [Full Text] [Related]  

  • 56. [Oxaluria, nonfamilial hyperoxaluric form of oxalic lithiasis].
    Desgrez P; Thomas J; David-Issartel R
    J Urol Nephrol (Paris); 1968 Sep; 74(9):685-9. PubMed ID: 5718185
    [No Abstract]   [Full Text] [Related]  

  • 57. The urinary excretion of oxalic acid in nephrolithiasis.
    HODGKINSON A
    Proc R Soc Med; 1958 Nov; 51(11):970-1. PubMed ID: 13614417
    [No Abstract]   [Full Text] [Related]  

  • 58. [Does vitamin E protect against experimental lithiasis?].
    Sakly A; Achour A; Zouaghi H
    Ann Urol (Paris); 1994; 28(5):265-7. PubMed ID: 7825984
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic effect of pyridoxine and succinimide in the treatment of a patient with primary hyperoxaluria].
    Jerez E; Rapado A
    Arch Esp Urol; 1986 May; 39(4):279-82. PubMed ID: 3740976
    [No Abstract]   [Full Text] [Related]  

  • 60. [The significance of oxaluria reduction in pyridoxine prevention of Ca-oxalate nephrolithiasis (author's transl)].
    Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B
    Cas Lek Cesk; 1982 Feb; 121(6):163-6. PubMed ID: 7060073
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.